Who are Maculaser's investors?

Maculaser's investors include Innovestor Ventures, ZEISS Ventures.

Where is Maculaser headquartered?

Maculaser is headquartered in Helsinki, FI.

Maculaser

Helsinki, FI · Founded 2020 · 5 employees on LinkedIn · 2 known investors

Find your way into Maculaser

186 people in our graph share verified history with the Maculaser team — schools, employers, funds. One of them is your warm intro.

Tanja Tervonenunlockedknows Jaakko Nieminen · together at Biodesign Finland (overlapped)

knows the team · via Biodesign Finland

×2knows the team · via University of Tuebingen

×8knows the team · via Aalto University

Maculaser develops a temperature-controlled retinal laser therapy to treat age-related macular degeneration, diabetic macular edema, and other retinal disorders by activating natural healing responses in eye cells. The company targets patients and healthcare providers globally for disease prevention and non-invasive retinal care.

Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Jani Tirronen CEOJani Tirronen is CEO of Maculaser, a medical technology company developing laser-based therapy for retinal diseases including age-related macular degeneration. He has over 20 years of experience across multiple industries.

Teemu TurunenChief Scientific Officer, PhD

Ossi Kaikkonen Head of ProductOssi Kaikkonen is a biomedical engineer with expertise in machine learning, digital signal processing, optics, and embedded systems design. As Head of Product at Maculaser, he develops a temperature-controlled retinal laser therapy platform to treat age-related macular degeneration and other retinal disorders.

Jaakko Nieminen CTO, PhDJaakko Nieminen is CTO of Maculaser, which develops temperature-controlled retinal laser therapy for age-related macular degeneration and related disorders. He has prior research experience in non-invasive brain stimulation and brain imaging at Aalto University, and established the Biodesign Finland MedTech innovation program.

Aki VartiainenClinical Trial Manager

Investors · 2

Innovestor Ventureslisted by Innovestor VenturesHelsinki · $270K – $3.2M

How we know: Innovestor Ventures's portfolio page · innovestorgroup.com · Not right? Tell us

ZEISS VenturesreportedOberkochen

How we know: press coverage · Not right? Tell us

Funding

SEC filings, press & company announcements

Undisclosed amountseed roundSep 2021
Innovestor Ventures (lead)
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Maculaser do?: Maculaser develops a temperature-controlled retinal laser therapy to treat age-related macular degeneration, diabetic macular edema, and other retinal disorders by activating natural healing responses in eye cells. The company targets patients and healthcare providers globally for disease prevention and non-invasive retinal care.
Who are Maculaser's investors?: Maculaser's investors include Innovestor Ventures, ZEISS Ventures.
Where is Maculaser headquartered?: Maculaser is headquartered in Helsinki, FI.